The linkurl:National Institutes of Health;http://www.nih.gov/ (NIH) and the linkurl:US Food and Drug Administration;http://www.fda.gov/ (FDA) linkurl:announced a new collaboration;http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm201706.htm this morning (Feb 24) that will support efforts in translational and regulatory science, including a contribution of $6.75 million in regulatory research grants over the next three years.
Since Margaret Hamburg took the reins as FDA commissioner last year, she has not been shy about her feelings regarding regulatory science -- research that relates the regulatory requirements of biomedical product development to the science that ensures the safety and efficacy of those products. If the production of new therapeutics were a rower, linkurl:Hamburg has said,;http://www.fda.gov/NewsEvents/Speeches/ucm191356.htm it would have one strong arm -- that of fundamental biomedical research and discovery -- but one scrawny arm -- the regulatory science counterpart. And unless the scrawny arm begins to bulk up, the translational side of research will largely just be moving in...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!